We suggest that for screening purposes neuropathologists employ any one of these three CK with the important addition of EMA as 2/3 of our CK negative synovial sarcomas were EMA positive (89% sensitivity of EMA for synovial sarcoma). This evidence concerns the gene MUC1 and synovial sarcoma.